With Hollywood performer set to get back to work movie theaters could still have a tough few months ahead

I'm David Brancatia with tentative deal between the sag after Union studios and, the strike that started in July has ended, but there's

a supply chain here and at one far end is the movie theater, Marketplace's Henry Epp reports. Tim Handran is CEO of Santicos Entertainment, a chain of movie theaters in San Antonio, Texas.

He's been warily watching a snag in his supply chain, but he says,

There's now a foreseeable end to the disruption

and the supply chain that's been going on for the last six months. The supply is

new movies coming to theaters. Production has been paused for most films and some releases have already been pushed back months, like the sequel to Dune, says Matthew Bellany, who covers the industry for Puck News.

Dune was supposed to come out last weekend and make a bunch of money.

It didn't and it was one of the lowest grossing weekends of the year.

And he says since studios are scrambling to restart productions,

there could be more disappointing weekends ahead.

Still, Tim Handran in San Antonio is optimistic.

He says the success of movies like Barbie this past summer showed audiences do want to come back to

theaters.

When there's content that's coming out, people are flocking to the movie theaters as they always have.

The question is, will there be enough content to keep that going?

I'm Henry App for Marketplace.

The FDA has approved an extra shot to help people lose weight. Eli Lilly's Zeppbound, sold under

the Monjaro name when used to treat diabetes.

Its new competition for the widely popular shot from Novo Nordisk called Wagovi, while these

drugs can quickly help people lose pounds, it's not yet clear how much they will add in the short term

or possibly subtract in the long run to health care costs here's marketplace

...